Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Gentamicin for Hereditary Hypotrichosis Simplex
NCT03492866Phase 2Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Apr 2018
- Primary completion
- Feb 2019
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
01
Overview
Phase 2, open-label trial of gentamicin in Hereditary hypotrichosis simplex (HHS) (2 arms), sponsored by Tel Aviv Sourasky Medical Center. Primary endpoint: Hair density over the scalp at 6 months. Status: unknown.
02
Drugs
gentamicin
03
Conditions
Hereditary hypotrichosis simplex (HHS)
Beyond the preview
Go deeper on NCT03492866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03492866.